⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PSTV News
PLUS THERAPEUTICS, Inc. Common Stock
Form 8-K
sec.gov
PSTV
Plus Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
PSTV
Plus Therapeutics Appoints Randy H. Goodman, PhD, MHA, as Vice President of Value Strategy & HEOR to Advance Market Access and Commercial Execution
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
KPRX
Plus Therapeutics Appoints Eric J. Daniels, M.D., MBA, as Chief Development Officer to Advance Clinical Pipeline
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas
globenewswire.com
PSTV
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
globenewswire.com
PSTV
Form 8-K
sec.gov
PSTV
Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives
globenewswire.com
PSTV